Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Novo agrees $2.6B deal for preclinical GLP-1/GIP drug from in-demand Hengrui

September 29, 2026
Continue Reading
novo-agrees-$2.6b-deal-for-preclinical-glp-1/gip-drug-from-in-demand-hengrui
Posted inBiotechnology

AstraZeneca scales Summit’s PD-1xVEGF strategy with $2B investment to fuel ADC combos

September 29, 2026
Continue Reading
astrazeneca-scales-summit’s-pd-1xvegf-strategy-with-$2b-investment-to-fuel-adc-combos
Posted inGenetics

AI Tool Helps Link BRSK1 Variants to Neurodevelopmental Disorder

September 28, 2026
Continue Reading
ai-tool-helps-link-brsk1-variants-to-neurodevelopmental-disorder
Posted inGenetics

Antibody Blocks T Cell Infiltration and Limits Neurodegeneration in Alzheimer’s Mice

September 28, 2026
Continue Reading
antibody-blocks-t-cell-infiltration-and-limits-neurodegeneration-in-alzheimer’s-mice
Posted inGenetics

Scientists Observe Enzymes Breaking Down DNA in Real Time

September 28, 2026
Continue Reading
scientists-observe-enzymes-breaking-down-dna-in-real-time
Posted inBiotechnology

Roche drops muscle-sparing obesity antibody after flunked interim analysis

September 28, 2026
Continue Reading
roche-drops-muscle-sparing-obesity-antibody-after-flunked-interim-analysis
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

oxford-nanopore-ceo-looks-beyond-native-dna,-rna-sequencing
Posted inGenetics

Oxford Nanopore CEO Looks Beyond Native DNA, RNA Sequencing

January 27, 2025
Oxford Nanopore Technologies is looking forward to “the year of the proteome,” as co-founder and CEO Gordon Sanghera, PhD, labeled…
Read More
long-read-nanopore-sequencing-improves-rare-disease-diagnosis
Posted inGenetics

Long-Read Nanopore Sequencing Improves Rare Disease Diagnosis

January 27, 2025
Whole genome sequencing (WGS) is not necessarily a solution for someone with a rare, monogenic disease. Indeed, more than half…
Read More
circulating-tumor-cell-cluster-size-decreased-with-digoxin-in-breast-cancer-patients
Posted inGenetics

Circulating Tumor Cell Cluster Size Decreased with Digoxin in Breast Cancer Patients

January 26, 2025
A proof-of-concept trial by researchers at ETH Zurich, the University Hospitals of Basel and Zurich, and the Basel-Land Cantonal Hospital,…
Read More
enhanced-survival-rates-observed-with-anatomic-lung-resection-in-early-stage-lung-cancer-patients
Posted inBiotechnology

Enhanced Survival Rates Observed with Anatomic Lung Resection in Early-Stage Lung Cancer Patients

January 25, 2025
New research unveiled at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting has significant implications for the surgical treatment…
Read More
synergistic-impact-of-dual-targeted-therapies-with-chemotherapy-achieves-promising-response-rates-in-braf-mutated-metastatic-colorectal-cancer
Posted inBiotechnology

Synergistic Impact of Dual-Targeted Therapies with Chemotherapy Achieves Promising Response Rates in BRAF-Mutated Metastatic Colorectal Cancer

January 25, 2025
In recent advancements in the treatment of metastatic colorectal cancer (mCRC) characterized by BRAF V600E mutations, researchers have announced compelling…
Read More
blood-test-from-alliance-trial-reveals-anti-inflammatory-drug’s-potential-to-reduce-colon-cancer-recurrence-risks
Posted inBiotechnology

Blood Test from Alliance Trial Reveals Anti-Inflammatory Drug’s Potential to Reduce Colon Cancer Recurrence Risks

January 25, 2025
The Alliance for Clinical Trials in Oncology has recently unveiled compelling findings from a randomized phase III clinical trial focused…
Read More
blood-test-may-inform-use-of-celecoxib-to-lower-colon-cancer-recurrence-risk
Posted inBiotechnology

Blood Test May Inform Use of Celecoxib to Lower Colon Cancer Recurrence Risk

January 25, 2025
A recent study from Dana-Farber Brigham Cancer Center has unveiled significant findings regarding the treatment of stage 3 colon cancer,…
Read More
mini-organs-in-a-dish-to-revolutionize-rare-disease-therapy
Posted inBiotechnology

Mini-Organs in a Dish to Revolutionize Rare Disease Therapy

January 25, 2025
Children born with rare genetic disorders often encounter a seemingly insurmountable succession of health challenges, each rooted in a missing…
Read More
how-microplastics-may-be-impacting-neurological-health
Posted inBiotechnology

How Microplastics May Be Impacting Neurological Health

January 25, 2025
Tiny plastic particles pervade nearly every corner of our planet, from remote ocean trenches to pristine polar ice fields. These…
Read More
revolutionary-dyes-enhance-photothermal-cancer-treatment-and-diagnostics
Posted inBiotechnology

Revolutionary Dyes Enhance Photothermal Cancer Treatment and Diagnostics

January 25, 2025
In a groundbreaking study from Tokyo Metropolitan University, a team of researchers has unveiled a revolutionary dye engineered to absorb…
Read More

Posts pagination

Previous page 1 … 2,276 2,277 2,278 2,279 2,280 … 2,374 Next page
You May Have Missed
Posted inMedical Technology

Precision Neuroscience taps $250M in Series D funding for brain-computer interface

Posted inMedical Technology

VC Sofinnova reels in €82M to target medtechs in the next 5 years

Posted inMedical Technology

Adagio Medical kicks off strategic review, trims more than half its staff

Posted inMedical Technology

Grail survives adcomm vote as it awaits FDA decision for cancer blood test

Privacy Policy    Terms

Scroll to Top